Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
NCT00307840
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Secondary Hyperparathyroidism
Interventions
DRUG:
paricalcitol
Sponsor
Papageorgiou General Hospital